Device Trial Radar · NCT07923565
CANLINK: Evaluation of the Intralink Intradiscal Device for Low Back Pain Due to Degenerative Disc Disease
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Jan 2027
Primary completion
Jul 2027
Study completion Jun 2029
Sponsor
- Lead sponsor
- Spinal Simplicity LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 6, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 22 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A single site, prospective study to evaluate the safety and performance of the Intralink device in participants with chronic or recurrent non-radicular discogenic low back pain (LBP) due to degenerative disc disease (DDD).
Conditions
- Degenerative Disc Disease(DDD)
Interventions
Pain treatmentDevice
Device: Intralink
Primary outcomes
What the sponsor says the trial is designed to measure.
- Oswestry Disability Index (ODI)Time frame: 1 Month compared to Baseline
- Assess occurrence of serious adverse events post-treatment.Time frame: Through 1 Month post procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Beam Radiology
Calgary, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.